A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/22 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2474964
It is intended to provide insulin resistance improving agents which contain, as the active ingredient, the C-terminal side spherical region of adiponectin C, adiponectin or genes thereof. It is also intended to provide remedies for type 2 diabetes which contain, as the active ingredient, the C-terminal side spherical region of adiponectin C, adiponectin or genes thereof. Thus, insulin resistance, which is induced by fat-rich diet and accompanied by obesity, can be improved and type 2 diabetes amounting the major part of diabetes can be treated.
L'invention concerne des agents améliorant la résistance à l'insuline, qui contiennent, comme principe actif, la région sphérique latérale C-terminale de l'adiponectine C, de l'adiponectine ou de leurs gènes. L'invention concerne en outre des remèdes contre le diabète non insulino-dépendant, qui contiennent, comme principe actif, la région sphérique latérale C-terminale de l'adiponectine C, de l'adiponectine ou de leurs gènes. La résistance à l'insuline, qui est induite par un régime riche en graisse et s'accompagne de l'obésité, peut être améliorée; et le diabète non insulino-dépendant, type de diabète le plus répandu, peut être traité.
Kadowaki Takashi
Kamon Junji
Kimura Satoshi
Nagai Ryozo
Tomita Motoo
Gowling Lafleur Henderson Llp
Japan Science And Technology Agency
LandOfFree
An insulin improving agent containing adiponectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with An insulin improving agent containing adiponectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An insulin improving agent containing adiponectin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1476875